Sialic acid residues are essential for the anaphylactic activity of murine IgG1 antibodies

Journal of Immunology

Volumn 181, Issue 12, 2008, Pages 8308-8314

  Silva, Sandriana R ^a   Casabuono, Adriana ^b   Jacysyn, Jacqueline F ^a   Favoretto, Bruna C ^a   Fernandes, Irene ^c   Macedo, Mahasti S ^a   Couto, Alicia S ^b   Faquim Mauro, Eliana L ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c INSTITUTO BUTANTAN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; FUCOSE; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G1 ANTIBODY; OLIGOSACCHARIDE; SIALIC ACID; IMMUNOGLOBULIN G; LECTIN; SIALIC ACID DERIVATIVE;

ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHEMICAL COMPOSITION; COMPLEMENT ACTIVATION; EFFECTOR CELL; GLYCOSYLATION; IMMUNOGLOBULIN STRUCTURE; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; AFFINITY CHROMATOGRAPHY; ANIMAL; ANTIBODY COMBINING SITE; BAGG ALBINO MOUSE; CELL LINE; CHEMISTRY; COMPARATIVE STUDY; CONFORMATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HYBRIDOMA; IMMUNOLOGY; ION EXCHANGE CHROMATOGRAPHY; METABOLISM; PHYSIOLOGY; STRUCTURE ACTIVITY RELATION;

ANAPHYLAXIS; ANIMALS; BINDING SITES, ANTIBODY; CARBOHYDRATE CONFORMATION; CELL LINE; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, ION EXCHANGE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYBRIDOMAS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; LECTINS; MAST CELLS; MICE; MICE, INBRED BALB C; OLIGOSACCHARIDES; SIALIC ACIDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 58849137588     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.12.8308     Document Type: Article

References (55)

1. Fridman, W. H. 1993. Regulation of B-cell activation and antigen presentation by Fc receptors. Curr. Opin. Immunol. 5: 355-360.
2. Clynes, R., and J. V. Ravetch. 1995. Cytotoxic antibodies trigger inflammation through Fc receptors. Immunity 3: 21-26.
3. Nimmerjahn, F., P. Bruhns, K. Horiuchi, and J. V. Ravetch. 2005. FcγRIV: a novel FcR with distinct IgG sublass specificity. Immunity 23: 41-51. (Pubitemid 41019656)
4. Jefferis, R., and J. Lund. 2002. Interaction sites on human IgG-Fc for FcγR: current models. Immunol. Lett. 82: 57-65. (Pubitemid 34468035)
5. Jefferis, R. 2005. Glycosylation of natural and recombinant antibody molecules. Adv. Exp. Med. Biol. 564: 143-148. (Pubitemid 43759228)
6. Arnold, J. N., M. R. Wormald, R. B. Sim, P. M. Rudd, and R. A. Dwek. 2007. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu. Rev. Immunol. 25: 21-50. (Pubitemid 46697901)
7. Rook, G. A. W., J. Steele, R. Brealey, A. Whyte, D. Isenberg, N. Sumar, J. L. Nelson, K. B. Bodman, A. Young, I. M. Roitt, et al. 1991. Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J. Autoimmun. 4: 779-794.
8. Rademacher, T. W., P. Williams, and R. A. Dwek. 1994. Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc. Natl. Acad. Sci. USA 91: 6123-6127.
9. Mimura, Y., S. Church, R. Ghirlando, P. R. Ashton, S. Dong, M. Goodall, J. Lund, and R. Jefferis. 2000. The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. Mol. Immunol. 37: 697-706. (Pubitemid 32244118)
10. Dijstelbloem, H. M., J. G. J. Van de Winkel, and C. G. M. Kallenberg. 2001. Inflammation in autoimmunity: receptors for IgG revisited. Trends Immunol. 22: 510-516.
11. Krapp, S., Y. Mimura, R. Jefferis, R. Ruber, and P. Sondermann. 2003. Structural analysis of human IgG-Fc glycosylation reveals a correlation between glycosylation and structural integrity. J. Mol. Biol. 31: 979-989.
12. Matsumiya, S., Y. Yamaguchi, J. Saito, M. Nagano, H. Sasakawa, S. Otaki, M. Satoh, K. Shitara, and K. Kato. 2007. Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1. J. Mol. Biol. 368: 767-779.
13. Parekh, R. B., R. A. Dwek, B. J. Sutton, D. L. Fernandes, A. Leung, D. Stanworth, T. W. Rademacher, T. Mizuochi, T. Taniguchi, K. Matuta, et al. 1985. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316: 452-457.
14. Wright, A., and S. L. Morrison. 1997. Effect of glycosylation on antibody function: implications for genetic engineering. Trends Biotechnol. 15: 26-32. (Pubitemid 27067150)
15. Amore, A., P. Cirina, G. Conti, P. Brusa, L. Peruzzi, and R. Coppo. 2001. Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J. Am. Soc. Nephrol. 12: 1862-1871.
16. Mestecky, J., M. Tomana, Z. Moldoveanu, B. A. Julian, H. Suzuki, K. Matousovic, M. B. Renfrow, L. Novak, R. J. Wyatt, and J. Novak. 2008. Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy. Kidney Blood Press. Res. 31: 29-37. (Pubitemid 351310031)
17. Mimura, Y., P. Sondermann, R. Ghirlando, J. Lund, S. P. Young, M. Goodall, and R. Jefferis. 2001. Role of oligosaccharide residues of IgG1-Fc in FcγRIIb binding. J. Biol. Chem. 276: 45539-144547
18. Ishizaka, K. 1989. Basic mechanisms of IgE-mediated hypersensitivity. Curr. Opin. Immunol. 1: 625-629.
19. Nissim, A., M. H. Jouvin, and Z. Eshhar. 1991. Mapping of the high affinity Fcε receptor binding site to the third constant region domain of IgE. EMBO J. 10: 101-107. (Pubitemid 21905271)
20. Costa, J. J., P. F. Weller, and S. J. Galli. 1997. The cells of the allergic response: mast cells, basophils and eosinophils. J. Am. Med. Assoc. 278: 1815-1822. (Pubitemid 28007255)
21. Hazenbos, W. L., J. E. Gessner, F. M. Hofhuis, H. Kuipers, D. Meyer, I. A. Heijnen, R. E. Schmidt, M. Sandor, P. J. Capel, M. Daëron, et al. 1996. Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD16) deficient mice. Immunity 5: 181-188.
22. Dombrowicz, D., V. Flamand, I. Mivajima, J. V. Ravetch, S. J. Galli, and J. P. Kinet. 1997. Absence of FcεRIα chain results in up-regulation of FcγRIII-dependent mast cell degranulation and anaphylaxis: evidence of competition between FcεRI and FcγRIII for limiting amounts of FcR β and γ chains. J. Clin. Invest. 99: 915-925.
23. Miyajima, I., D. Dombrowicz, T. R. Martin, J. V. Ravetch, J. P. Kinet, and S. J. Galli. 1997. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII: assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J. Clin. Invest. 99: 901-914. (Pubitemid 27123627)
24. Faquim-Mauro, E. L., R. L. Coffman, I. A. Abrahamsohn, and M. S. Macedo. 1999. Cutting edge: mouse IgG1 antibodies comprise two functionally distinct types that are differentially regulated by IL-4 and IL-12. J. Immunol. 163: 3572-3576.
25. Faquim-Mauro, E. L., and M. S. Macedo. 2000. Induction of IL-4 dependent, anaphylactic-type and IL-4-independent, non-anaphylactic-type IgG1 antibodies is modulated by adjuvants. Int. Immunol. 12: 1733-1740.
26. Faquim-Mauro, E. L., J. F. Jacysyn, and M. S. Macedo. 2003. Anaphylactic and non-anaphylactic murine IgG1 differ in their ability to bind to mast cells: relevance of proper glycosylation of the molecule. Immunobiology 207: 169-177.
27. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
28. Coulter, A., and R. Harris. 1983. Simplified preparation of rabbit Fab fragments. J. Immunol. Methods 59: 199-203.
29. Ovary, Z. 1958. Passive cutaneous anaphylaxis in the mouse. J. Immunol. 81: 355-357.
30. Ortega, E., H. Schneider, and I. Pecht. 1991. Possible interactions between the Fcε receptor and a novel mast cell function-associated antigen. Int. Immunol. 3: 333-342.
31. Verbet, A. 1995. Methods on Glycoconjugates, a Laboratory Manual. Academic Publishers, Switzerland.
32. Zar, J. H. 1984. Biostatistical Analysis. Prentice Hall, New York.
33. Goldstein, I. J., and C. E. Hayes. 1978. The lectins: carbohydrate-binding proteins of plants and animals. Adv. Carbohydr. Chem. Biochem. 35: 127-340.
34. Mandal, C., and C. Mandal. 1990. Sialic acid binding lectins. Experientia 46: 433-441.
35. Strait, R. T., S. C. Morris, M. Yang, X. W. Qu, and F. D. Finkelman. 2002. Pathways of anaphylaxis in the mouse. J. Allergy Clin. Immunol. 109: 658-668.
36. Finkelman, F. D., M. E. Rothenberg, E. B. Brandt, S. C. Morris, and R. T. Strait. 2005. Molecular mechanisms of anaphylaxis: lessons from studies with murine models. J. Allergy Clin. Immunol. 115: 449-457. (Pubitemid 40341692)
37. Vanderhoek, J. Y., N. S. Tare, J. M. Bailey, A. L. Goldstein, and D. H. Pluznik. 1982. New role for 15-hydroxyeicosatetraenoic acid: activator of leukotriene bio-synthesis in PT-18 mast/basophil cells. J. Biol. Chem. 257: 12191-12195. (Pubitemid 13180117)
38. Malhotra, R., M. R. Wormald, P. M. Rudd, P. B. Fischer, and R. B. Sim. 1995. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat. Med. 1: 237-243.
39. Farooq, M., N. Takahashi, H. Arrol, M. Drayson, and R. Jefferis. 1997. Glycosylation of polyclonal and paraprotein IgG in multiple myeloma. Glycoconj. J. 14: 489-492.
40. Jefferis, R., J. Lund, and J. D. Pound. 1998. IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation. Immunol. Rev. 163: 59-76. (Pubitemid 28327862)
41. Jefferis, R., and J. Lund. 1997. Glysosylation of antibody molecules: structural and functional significance. Chem. Immunol. 65: 111-128. (Pubitemid 27029829)
42. Kaneko, Y., F. Nimmerjahn, and J. V. Ravetch. 2006. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313: 670-673. (Pubitemid 44201145)
43. Lowe, J. B., and J. D. Marth. 2003. A genetic approach to mammalian glycan function. Annu. Rev. Biochem. 72: 643-691.
44. Varki, A. 1999. Sialic acid. In Essential of Glycobiology. 1st Ed. A. Varki, J. Esko, R. Cunnings, H. Freeze, G. Hart, and J. Marth, eds. Cold Spring Harbor Laboratory Press, Woodbury, NY, pp. 195-209.
45. Ferrara, C., P. Brunker, T. Suter, S. Moser, U. Puntener, and P. Umana. 2006. Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and coexpression of heterologous β1, 4-N-acetylglucosaminyltransferase III and Golgi α-mannosidase II. Biotechnol. Bioeng. 93: 851-861.
46. Schachter, H. 2001. The clinical relevance of glycobiology. J. Clin. Invest. 108: 1579-1582.
47. Lehmann, F., E. Tiralongo, and J. Tiralongo. 2006. Sialic acid-specific lectins: occurrence, specificity and function. Cell. Mol. Life Sci. 63: 1331-1354. (Pubitemid 43939016)
48. Granado, D. A., and J. R. Neeser. 1987. Effect of trimming inhibitors on the secretion and biological activity of a murine IgE monoclonal antibody. Mol. Immunol. 24: 849-855.
49. Masuda, Y., Y. Akagawa, and Y. Hishikawa. 2001. Another anti-allergic mechanism: antibody IgE deglycosylation induced by a substance extracted from human urine. Yale J. Biol. Med. 74: 145-149. (Pubitemid 32726052)
50. Takai, T., M. Ono, M. Hikida, H. Ohmori, and J. V. Ravetch. 1996. Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature 379: 346-349.
51. Shields, R. L., J. Lai, R. Keck, L. Y. O'Connell, K. Hong, Y. G. Meng, S. H. Weikert, and L. G. Presta. 2002. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity. J. Biol. Chem. 277: 26733-26740.
52. Nishiura, T., S. Fujii, Y. Kanayama, A. Nishikawa, Y. Tomiyama, M. Iida, T. Karasuno, H. Nakao, T. Yonezawa, N. Taniguchi, et al. 1990. Carbohydrate analysis of immunoglobulin G myeloma proteins by lectin and high performance liquid chromatography: role of glycosyltransferases in the structures. Cancer Res. 50: 5345-5350. (Pubitemid 20302986)
53. Frithz, G., G. Ronquist, and P. Ericsson. 1985. Serum sialyltransferase and fucosyltransferase activities in patients with multiple myeloma. Eur. J. Cancer Clin. Oncol. 21: 913-917. (Pubitemid 15003372)
54. Cohen, A. M., D. Allalouf, H. Bessler, M. Djaldetti, T. Malachi, and H. Levinsky. 1989. Sialyltransferase activity and sialic acid levels in multiple myeloma and monoclonal gammopathy. Eur. J. Immunol. 42: 289-292.
55. Fleming, S. C., S. Smith, D. Knowles, A. Skillen, and C. H. Self. 1998. Increased sialylation of oligosaccharides on IgG paraproteins: a potential new tumor marker in multiple myeloma. J. Clin. Pathol. 51: 825-830.